Similarly, over-expression of chloroplastic MDHAR from L
Gastrointestinal Side Effects The most common adverse events were gastrointestinal in nature, as expected for this drug class: Nausea the most frequently reported GI side effect, typically most pronounced during dose escalation and diminishing over time Diarrhea reported at moderate frequency Constipation less common than nausea but clinically relevant for some participants Vomiting generally mild and often transient These GI effects are mechanistically linked to GLP-1 receptor activation (slowed gastric emptying, central appetite suppression) and are a recognized feature of all GLP-1-based therapies
Treatment Options for Rhabdomyolysis Managing rhabdomyolysis, a condition where a large amount of muscle tissue breaks down and releases substances into the blood that can damage the kidneys, is all about replenishing fluids in the body and protecting the kidneys
Documentation requirements typically include photographs, medical records of skin conditions, and failed conservative treatment attempts
For example, treatment might begin with a small dose, like 0.25 mg of Semaglutide weekly, which can be increased over time based on your progress and how well your body tolerates it
When should I seek urgent medical help for dizziness on GLP-1 therapy
